AECI Limited - Dealings in securities by a Director, a Prescribed Officer and the Group Company Secretary

AECI LIMITED

(Incorporated in the Republic of South Africa)

Registration number: 1924/002590/06

Share code: AFE ISIN: ZAE000000220

Hybrid code: AFEP ISIN: ZAE000000238

Bond company code: AECI

LEI: 3789008641F1D3D90E85

(AECI or the Company)

 

DEALINGS IN SECURITIES BY A DIRECTOR, A PRESCRIBED OFFICER AND THE GROUP COMPANY SECRETARY

In compliance with paragraphs 3.63 to 3.74 of the JSE Limited Listings Requirements (Listings Requirements), the following information is disclosed:

 

Acceptance of awards of performance shares: Long-term Incentive Plan (LTIP)

In terms of the standard rules of the Company's LTIP, participants have been allocated new awards of performance shares in line with an annual award process.   These will convert into AECI ordinary shares and will vest three years after the grant date of 14 April 2025, subject to the performance conditions attached to each allocation being met.   The   awards of performance shares were accepted by the relevant participants on 7   May   2025 and the performance shares were issued at the grant price of R92.9000 on the same date, as follows:

 


Name            Position and company       Number of performance Value
                                           shares

H Riemensperger Chief Executive Officer,   128 734               R11 959 388.60
                AECI

                Prescribed Officer, AECI
DK Murray       (Executive Vice President, 43 547                R4 045 516.30
                AECI Chemicals)

C Singh         Group Company Secretary,   33 077                R3 072 853.30
                AECI



 

Acceptance of awards of shares: 2024 One Incentive Long-term Incentive Plan (OI-LTIP)

In terms of the standard rules of the Company's 2024 OI-LTIP, participants have been allocated new awards of non-performance shares in line with an annual award process.   These will convert into AECI ordinary shares and will vest two years after the grant date of 14 April 2025, subject to the conditions attached to each allocation being met.   The awards of non-performance shares were accepted by the relevant participants on 7 May 2025 and the non-performance shares were issued at the grant price of R92.9000 on the same date, as follows:

 


Name            Position and company                Number of shares Value

H Riemensperger Chief Executive Officer, AECI       9 925            R922 032.50

DK Murray       Prescribed Officer, AECI (Executive 3 580            R332 582.00
                Vice President, AECI Chemicals)

C Singh         Group Company Secretary, AECI       3 055            R283 809.50



 

The abovementioned transactions, for which the prescribed clearance was granted in terms of paragraph 3.66 of the Listings Requirements, were effected off-market. All participants have a direct beneficial interest.

 

Woodmead, Sandton

8 May 2025

 

 

Equity Sponsor:   One Capital

 

Debt Sponsor:   Questco